/ -- Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences Ltd., its subsidiary for the API (Active Pharmaceuticals Ingredients) business.
(Logo: https://bsmedia.business-standard.commma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg )
About Glenmark Pharmaceuticals
Disclaimer: No Business Standard Journalist was involved in creation of this content